Loading...
Loading...
India's melatonin imports from UNITED KINGDOM total $4.3K across 9 shipments from 6 foreign suppliers. ABCAM PLC leads with $1.2K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include STRIDES PHARMA SCIENCE LIMITED. This corridor reflects India's pharmaceutical import demand for melatonin โ a diversified sourcing base with multiple active suppliers from UNITED KINGDOM.

ABCAM PLC is the leading Melatonin supplier from UNITED KINGDOM to India, with import value of $1.2K across 2 shipments. The top 5 suppliers โ ABCAM PLC, E-PHARMA LIMITED, E PHARM LIMITED, ABCAM SINGAPORE PTE LTD.,, ESPEE PHARMA (UK) LTD. โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ABCAM PLC | $1.2K | 2 | 26.7% |
| 2 | E-PHARMA LIMITED | $1.1K | 1 | 25.5% |
| 3 | E PHARM LIMITED | $818 | 1 | 18.9% |
| 4 | ABCAM SINGAPORE PTE LTD., | $745 | 2 | 17.2% |
| 5 | ESPEE PHARMA (UK) LTD. | $507 | 2 | 11.7% |
| 6 | WAYMADE PLC. | $2 | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | STRIDES PHARMA SCIENCE LIMITED | $1.9K | 2 | 44.4% |
| 2 | ALLIED SCIENTIFIC PRODUCTS., | $1.2K | 2 | 26.7% |
| 3 | NULIFE CONSULTANTS AND DISTRIBUTORS PRIVATE LIMITE |
UNITED KINGDOM โ India trade corridor intelligence
The United Kingdom to India trade corridor for pharmaceutical imports, including Melatonin formulations, is currently stable. Major ports such as Jawaharlal Nehru Port Trust (JNPT), Chennai, and Mundra are operating efficiently, with minimal congestion. Freight rates have remained consistent, and the exchange rate between the Indian Rupee (INR) and the British Pound Sterling is favorable for importers. However, importers should monitor any geopolitical developments that could impact trade dynamics.
India's Production Linked Incentive (PLI) scheme aims to boost domestic manufacturing, potentially reducing the need for imports of finished pharmaceutical formulations like Melatonin. Import substitution policies are being considered to enhance self-reliance, but the transition may take time. Importers should assess the evolving policy landscape and adapt their strategies accordingly.
The trade relationship between India and the United Kingdom is robust, with ongoing negotiations to strengthen ties. Discussions on mutual recognition of Good Manufacturing Practices (GMP) and other regulatory harmonization efforts are underway to facilitate smoother pharmaceutical trade. Importers should stay informed about these developments to leverage potential benefits.
| $745 |
| 2 |
| 17.2% |
| 4 | TORRENT PHARMACEUTICALS LTD | $507 | 2 | 11.7% |
| 5 | APOTHECON PHARMACEUTICALS PRIVATE LIMITED | $2 | 1 | 0.0% |
The landed cost of importing Melatonin formulations from the United Kingdom to India includes the Free on Board (FOB) price, freight charges, insurance, Basic Customs Duty (BCD) of 10%, Education Cess of 2%, Secondary Higher Education Cess of 1%, Countervailing Duty (CVD) of 6%, and the Integrated Goods and Services Tax (IGST). Additional costs such as port handling and Customs House Agent (CHA) charges may also apply. Importers should calculate the total landed cost to determine the final price of the product in the Indian market.
CDSCO registration, import licensing, and quality testing requirements
Importing finished pharmaceutical formulations containing Melatonin into India requires compliance with regulations set by the Central Drugs Standard Control Organisation (CDSCO). Importers must obtain a valid Importer License from the Directorate General of Foreign Trade (DGFT). Each batch of Melatonin formulations must be registered with the CDSCO, which involves submitting Form CT-20/40/41, along with necessary documents such as the Certificate of Pharmaceutical Product (CoPP), Certificate of Analysis (CoA), and stability data. The registration process typically takes several months, depending on the completeness of the application and the CDSCO's workload. Melatonin formulations under HS Code 30049099 are subject to these registration requirements to ensure safety and efficacy.
Upon arrival in India, each batch of imported Melatonin formulations undergoes quality testing at CDSCO-approved laboratories. Importers must provide a CoA and stability data demonstrating compliance with Indian Pharmacopoeia standards. Port inspections by customs drug inspectors are conducted to verify the authenticity and quality of the products. If a batch fails to meet the required standards, it may be rejected, leading to potential financial losses and reputational damage for the importer.
Between 2024 and 2026, the CDSCO has implemented stricter regulations for importing finished pharmaceutical formulations, including Melatonin. The introduction of the Production Linked Incentive (PLI) scheme has encouraged domestic manufacturing, potentially reducing reliance on imports. Bilateral agreements between India and the United Kingdom have facilitated smoother trade relations, but importers must stay updated on policy changes to ensure compliance.
Market demand, customs duty structure, and competitive landscape ยท Import duty: 17.10%
India imports finished Melatonin formulations to meet domestic demand for sleep disorders and related health issues. The market size for Melatonin formulations in India is substantial, with a total export market of $9.4 million across 116 exporters to 51 countries. Domestic production may not fully satisfy the demand, leading to reliance on imports from countries like the United Kingdom.
The import duty for Melatonin formulations under HS Code 30049099 includes a Basic Customs Duty (BCD) of 10%, an Education Cess of 2%, a Secondary Higher Education Cess of 1%, and a Countervailing Duty (CVD) of 6%. The total duty amounts to 17.10%. Importers should also account for the Integrated Goods and Services Tax (IGST) applicable to the product. Exemptions or concessional rates may apply under specific circumstances or trade agreements.
The United Kingdom is a preferred source for Melatonin formulations due to its established pharmaceutical industry, adherence to stringent quality standards, and innovative product offerings. While other suppliers like China, Germany, and the United States also export Melatonin formulations to India, the United Kingdom's reputation for quality and reliability gives it a competitive edge. The United Kingdom's share in India's Melatonin import market is significant, reflecting its strong position.
Import rationale, competitive comparison, supply chain risk, and procurement strategy
India imports Melatonin formulations from the United Kingdom due to the latter's advanced pharmaceutical manufacturing capabilities, adherence to international quality standards, and the availability of specialized dosage forms not produced domestically. The United Kingdom's established reputation in the pharmaceutical industry makes it a reliable source for high-quality Melatonin formulations.
Compared to other suppliers like China, Germany, and the United States, the United Kingdom offers superior quality assurance, compliance with international regulatory standards, and a diverse range of Melatonin formulations. While other countries may offer competitive pricing, the United Kingdom's emphasis on quality and reliability provides a unique advantage for Indian importers seeking consistent and safe products.
Indian importers face risks such as dependency on a single source, currency fluctuations, regulatory changes, quality control issues, and potential shipping disruptions. To mitigate these risks, importers should diversify their supplier base, maintain adequate inventory levels, and establish contingency plans for unforeseen disruptions.
Import license checklist, document requirements, quality testing, and compliance
Upon arrival, customs drug inspectors collect samples of each batch for testing at CDSCO-approved laboratories. Mandatory batch testing ensures compliance with Indian Pharmacopoeia standards. The testing process includes verifying the product's identity, purity, potency, and stability. If a batch fails to meet the required standards, it may be rejected, leading to potential financial losses and reputational damage for the importer. Importers should ensure that all
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Melatonin suppliers from UNITED KINGDOM to India include ABCAM PLC, E-PHARMA LIMITED, E PHARM LIMITED. The leading supplier is ABCAM PLC with import value of $1.2K USD across 2 shipments. India imported Melatonin worth $4.3K USD from UNITED KINGDOM in total across 9 shipments.
India imported Melatonin worth $4.3K USD from UNITED KINGDOM across 9 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Melatonin sourced from UNITED KINGDOM include STRIDES PHARMA SCIENCE LIMITED, ALLIED SCIENTIFIC PRODUCTS.,, NULIFE CONSULTANTS AND DISTRIBUTORS PRIVATE LIMITE. The largest buyer is STRIDES PHARMA SCIENCE LIMITED with $1.9K in imports across 2 shipments.
The total value of Melatonin imports from UNITED KINGDOM to India is $4.3K USD, across 9 shipments and 6 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9 Verified Shipments
6 suppliers, 5 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists